BioNTech SE Income Statement (2018-2025) | BNTX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Revenue & cost
Revenue	0.02B	0.07B	0.03B	0.03B	0.03B	0.03B	0.03B	0.05B	0.08B	411,816.90B	2.47B	6.39B	7.18B	6.33B	7.15B	3.41B	3.49B	4.36B	1.37B	0.18B	0.97B	1.59B	0.20B	0.14B	1.37B	1.27B	0.19B	0.30B	1.78B
Cost of Revenue	3.23	0.00B	0.00B	0.01B	4.71	0.02B	6.51	0.01B	0.01B	48.88	0.28B	1.06B	1.43B	0.67B	1.45B	0.82B	0.76B	0.19B	0.10B	0.18B	0.18B	0.19B	0.06B	0.06B	0.20B	0.26B	0.09B	0.09B	0.17B
Gross Profit	0.02B	0.07B	0.03B	0.02B	0.03B	0.03B	0.02B	0.04B	0.07B	411,816.90B	2.19B	5.33B	5.75B	5.66B	5.70B	2.59B	2.73B	4.18B	1.27B	0.01B	0.80B	1.40B	0.14B	0.07B	1.17B	1.01B	0.10B	0.21B	1.60B
Operating items
Research & Development	-0.04B	0.10B			-0.06B	0.43B	-0.07B			-306.42	-0.26B	-0.24B	-0.31B	-0.31B	-0.32B	-0.43B	-0.34B	-0.52B	-0.36B	-0.41B	-0.54B	-0.62B	-0.55B	-0.63B	-0.60B	-0.65B	-0.55B	-0.58B	-0.66B
Share-based Compensation (IS)														-0.00B	-0.00B	-0.00B	-0.00B	-0.05B	-0.78B	-0.03B	-0.00B	-0.01B	-0.00B	-0.01B	-0.15B	-0.01B	-0.00B	-0.01B	-0.00B
Selling, General & Administrative	-0.01B	0.02B			-0.01B	0.09B	-0.02B			-42.80	-0.05B	-0.06B	-0.08B	-0.15B	-0.10B	-0.14B	-0.14B	-0.12B	-0.12B	-0.13B	-0.15B	-0.13B	-0.13B	-0.18B	-0.15B	-0.12B	-0.11B	-0.13B	-0.14B
Other Operating Expenses																				0.00B	0.00B	0.00B		-0.00B		-0.00B	-0.00B		-0.00B
Operating Expenses	-0.05B	0.12B			-0.07B	0.52B	-0.09B			-349.22	-0.31B	-0.30B	-0.39B	-0.46B	-0.42B	-0.57B	-0.49B	-0.64B	-0.48B	-0.54B	-0.69B	-0.76B	-0.68B	-0.81B	-0.75B	-0.77B	-0.67B	-0.71B	-0.80B
Operating Income	25.16	0.00B	0.05B	0.05B	0.04B	-0.34B	0.07B	0.09B	0.00	291,157.17B	2.01B	5.06B	5.57B	0.00B	5.33B	2.36B	2.41B	3.36B	0.70B	-0.61B	0.08B	0.57B	-0.55B	-1.04B	0.01B	0.16B	-0.56B	-0.57B	-0.05B
EBIT	25.16	0.00B	0.05B	0.05B	0.04B	-0.34B	0.07B	0.09B	0.00	291,157.17B	2.01B	5.06B	5.57B	0.00B	5.33B	2.36B	2.41B	3.36B	0.70B	-0.61B	0.08B	0.57B	-0.55B	-1.04B	0.01B	0.16B	-0.56B	-0.57B	-0.05B
Non-operating items
Interest & Investment Income	0.00B	0.00B			0.01B	-0.01B	0.01B	-0.01B	0.00B	-0.60	0.03B	0.00B	0.03B	0.02B	0.31B	0.12B	0.06B	0.04B	0.09B	0.17B	0.17B	0.17B	0.20B	0.18B	0.17B	0.18B	0.13B	0.12B	0.11B
Other Non Operating Income							0.01B	-0.01B	-0.02B		0.03B	-0.00B	0.03B		0.03B	0.15B	0.03B		-0.03B	0.03B	0.01B		0.01B	-0.00B	-0.00B		-0.03B	-0.00B
Non Operating Income							0.01B	-0.00B	0.02B		0.02B	0.21B	0.07B		0.32B	0.30B	0.11B		0.06B	0.16B	0.17B		0.19B	0.17B	0.16B		0.09B	0.11B
Net income details
EBT	0.03B	-0.05B	0.05B	0.06B	0.03B	-0.33B	0.06B	0.10B	0.24B	245.13	1.98B	4.84B	5.50B	5.39B	5.63B	2.47B	2.46B	3.24B	0.76B	-0.45B	0.25B	0.71B	-0.36B	-0.87B	0.17B	0.32B	-0.47B	-0.46B	0.03B
Tax Provisions	-0.00B	0.00B			-0.00B	-0.00B		0.00B		-192.32	620.25	-1.49B	3.78B	-1.77B	-1.48B	-0.69B	-0.66B	0.91B	0.22B	-0.24B	0.07B	-0.22B	-0.02B	-0.00B	-0.04B	0.04B	0.03B	0.02B	-0.06B
Profit After Tax	0.03B	-0.05B	0.05B	0.06B	0.03B	-0.33B	0.06B	0.10B	0.25B	437.45	1.36B	3.36B	3.79B	3.62B	4.15B	1.78B	1.80B	2.32B	0.54B	-0.21B	0.17B	0.49B	-0.34B	-0.87B	0.22B	0.28B	-0.44B	-0.44B	-0.03B
Equity Income	-0.00B	0.00B
Income from Non-Controlling Interests	-0.00B	0.00B				0.00B
Income from Continuing Operations	0.03B	-0.05B	0.05B	0.06B	0.03B	-0.33B	0.06B	0.10B	0.24B	437.45	1.98B	6.33B	1.72B	7.16B	7.11B	3.17B	3.13B	2.32B	0.54B	-0.21B	0.17B	0.93B	-0.34B	-0.87B	0.22B	0.28B	-0.50B	-0.47B	0.09B
Consolidated Net Income	0.03B	-0.05B	0.05B	0.06B	0.03B	-0.33B	0.06B	0.10B	0.24B	437.45	1.98B	6.33B	1.72B	7.16B	7.11B	3.17B	3.13B	2.32B	0.54B	-0.21B	0.17B	0.93B	-0.34B	-0.87B	0.22B	0.28B	-0.50B	-0.47B	0.09B
Income towards Parent Company	-0.03B	0.05B	0.05B	0.06B	-0.03B	-0.06B	0.06B	0.10B	0.24B	437.45	1.98B	6.33B	1.72B	0.00B	7.11B	3.17B	3.13B	2.32B	0.54B	-0.21B	0.17B	0.93B	-0.34B	-0.87B	0.22B	0.28B	-0.50B	-0.47B	0.09B
Net Income towards Common Stockholders	-0.03B	0.05B	0.05B	0.06B	-0.03B	-0.06B	0.06B	0.10B	0.24B	437.45	1.98B	6.33B	1.72B	0.00B	7.11B	3.17B	3.13B	2.32B	0.54B	-0.21B	0.17B	0.93B	-0.34B	-0.87B	0.22B	0.28B	-0.50B	-0.47B	0.09B
Additional items
EPS (Basic)	0.14	0.00B			0.16	-0.00B															0.00B	0.00B			0.00B	0.00B
EPS (Weighted Average and Diluted)																					0.00B	0.00B			0.00B	0.00B
Shares Outstanding (Weighted Average)		285.35				940.85															0.00B	0.00B			900.54	0.00B
Shares Outstanding (Diluted Average)																					0.00B	0.00B			889.56	0.00B
EBITDA	25.16	0.00B	0.05B	0.05B	0.04B	-0.34B	0.07B	0.09B	0.00	291,157.17B	2.01B	5.06B	5.57B	0.00B	5.33B	2.36B	2.41B	3.36B	0.70B	-0.61B	0.08B	0.57B	-0.55B	-1.04B	0.01B	0.16B	-0.56B	-0.57B	-0.05B
Interest Expenses	-0.00B	0.00B			-0.00B	0.00B	-0.00B	-0.00B	0.02B	-46.62	53.92	-0.21B	0.36B	-0.00B	-0.01B	-0.01B	-0.00B	-0.16B	-0.03B	-0.00B	-0.00B	-0.03B	-0.01B	-0.01B	-0.01B	-0.01B	-0.04B	-0.01B	-0.03B
Tax Rate	-2.50%	-1.26%			-0.03%	0.06%		2.43%		-78.45%	0.00%	-30.71%	68.69%	-32.83%	-26.29%	-27.91%	-26.97%	28.18%	29.04%	53.81%	29.38%	-30.96%	5.03%	0.25%	-24.83%	13.84%	-6.65%	-4.00%	-216.19%

Research Tools

BioNTech SE Income Statement (2018-2025) | BNTX

Create an account

Sign In

Reset Password